Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | DNA helicase recq1 | 0.0012 | 0.0004 | 0.0004 |
Loa Loa (eye worm) | hypothetical protein | 0.0146 | 0.0107 | 0.0104 |
Echinococcus granulosus | thymidylate synthase | 0.0456 | 0.0345 | 0.0342 |
Giardia lamblia | Sgs1 DNA helicase, putative | 0.0012 | 0.0004 | 0.5 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.556 | 0.4258 | 1 |
Echinococcus granulosus | ATP dependent DNA helicase Q1 | 0.0012 | 0.0004 | 0.0002 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.0106 | 0.0103 |
Schistosoma mansoni | blooms syndrome DNA helicase | 0.0023 | 0.0013 | 0.0013 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.0038 | 0.0035 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.001 | 0.0007 |
Echinococcus multilocularis | ATP dependent DNA helicase Q1 | 0.0012 | 0.0004 | 0.0002 |
Mycobacterium tuberculosis | Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) | 1.305 | 1 | 1 |
Schistosoma mansoni | smad1 5 8 and | 0.001 | 0.0003 | 0.0003 |
Echinococcus multilocularis | geminin | 0.0205 | 0.0152 | 0.0149 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.001 | 0.001 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0019 | 0.001 | 0.0007 |
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.556 | 0.4258 | 1 |
Chlamydia trachomatis | dihydrofolate reductase | 1.305 | 1 | 0.5 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0012 | 0.0004 | 0.0011 |
Echinococcus granulosus | geminin | 0.0205 | 0.0152 | 0.0149 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.0106 | 0.0103 |
Echinococcus granulosus | dihydrofolate reductase | 1.305 | 1 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0038 | 0.0035 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0019 | 0.001 | 0.0007 |
Schistosoma mansoni | TGF-beta signal transducer Smad2 | 0.001 | 0.0003 | 0.0003 |
Schistosoma mansoni | smad | 0.001 | 0.0003 | 0.0003 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0038 | 0.0038 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0041 | 0.0039 |
Schistosoma mansoni | Smad4 | 0.001 | 0.0003 | 0.0003 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.0038 | 0.0035 |
Loa Loa (eye worm) | thymidylate synthase | 0.0456 | 0.0345 | 0.0342 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.0029 | 0.0018 | 0.067 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0027 | 0.0024 |
Echinococcus granulosus | GPCR family 2 | 0.0019 | 0.001 | 0.0007 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.0152 | 0.0152 |
Loa Loa (eye worm) | dihydrofolate reductase | 1.305 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0041 | 0.0039 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.001 | 0.0007 |
Loa Loa (eye worm) | RecQ helicase | 0.0029 | 0.0018 | 0.0015 |
Mycobacterium ulcerans | dihydrofolate reductase DfrA | 1.305 | 1 | 1 |
Mycobacterium leprae | DIHYDROFOLATE REDUCTASE DFRA (DHFR) (TETRAHYDROFOLATE DEHYDROGENASE) | 1.305 | 1 | 1 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.0456 | 0.0345 | 0.0186 |
Echinococcus granulosus | bloom syndrome protein | 0.0029 | 0.0018 | 0.0015 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.0004 | 0.0002 |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.0012 | 0.0004 | 0.0002 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0038 | 0.0038 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.001 | 0.0007 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.556 | 0.4258 | 1 |
Brugia malayi | Bloom's syndrome protein homolog | 0.0029 | 0.0018 | 0.0015 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0012 | 0.0004 | 0.0011 |
Plasmodium falciparum | ADP-dependent DNA helicase RecQ | 0.0025 | 0.0015 | 0.0024 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.001 | 0.001 |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.0012 | 0.0004 | 0.0002 |
Schistosoma mansoni | DNA helicase recq5 | 0.0012 | 0.0004 | 0.0004 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.0152 | 0.0152 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.556 | 0.4258 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0038 | 0.0035 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0019 | 0.001 | 0.0007 |
Echinococcus multilocularis | bloom syndrome protein | 0.0029 | 0.0018 | 0.0015 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.001 | 0.001 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0041 | 0.0039 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0041 | 0.0039 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.556 | 0.4258 | 1 |
Echinococcus multilocularis | thymidylate synthase | 0.0456 | 0.0345 | 0.0342 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase, putative | 0.0217 | 0.0162 | 0.0363 |
Brugia malayi | Dihydrofolate reductase | 1.305 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0217 | 0.0162 | 0.0159 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0027 | 0.0024 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.001 | 0.001 |
Trichomonas vaginalis | DNA helicase recq1, putative | 0.0029 | 0.0018 | 0.067 |
Schistosoma mansoni | smad1 5 8 and | 0.001 | 0.0003 | 0.0003 |
Echinococcus multilocularis | dihydrofolate reductase | 1.305 | 1 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0038 | 0.0035 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0027 | 0.0027 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0456 | 0.0345 | 0.0345 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0038 | 0.0038 |
Entamoeba histolytica | recQ family helicase, putative | 0.0015 | 0.0007 | 1 |
Brugia malayi | thymidylate synthase | 0.0456 | 0.0345 | 0.0342 |
Loa Loa (eye worm) | ATP-dependent DNA helicase | 0.0012 | 0.0004 | 0.0002 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0217 | 0.0162 | 1 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.001 | 0.0007 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.0106 | 0.0103 |
Echinococcus granulosus | ATP dependent DNA helicase Q5 | 0.0012 | 0.0004 | 0.0002 |
Echinococcus multilocularis | ATP dependent DNA helicase Q5 | 0.0012 | 0.0004 | 0.0002 |
Onchocerca volvulus | 0.0456 | 0.0345 | 0.5 | |
Schistosoma mansoni | smad1 5 8 and | 0.001 | 0.0003 | 0.0003 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0019 | 0.001 | 0.0024 |
Schistosoma mansoni | dihydrofolate reductase | 1.305 | 1 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0038 | 0.0035 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.001 | 0.0007 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.556 | 0.4258 | 1 |
Echinococcus multilocularis | GPCR, family 2 | 0.0019 | 0.001 | 0.0007 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -6.657 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -6.421 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.914 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.711 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.623 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.421 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.376 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.254 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.491 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.